Leading U.S. infectious disease expert Anthony Fauci warns of a rushed approval of a coronavirus vaccine candidate. „The only thing you don’t want to see with a vaccine is an Emergency Use Authorization (Note) before you have evidence of its effectiveness,“ Fauci told Reuters in a telephone interview yesterday.
„One of the potential dangers of rushing a vaccine to market is that it will make it difficult – if not impossible – for the other vaccine candidates to get test subjects involved in their study,“ said the director of the NIAID Institute of Allergy and infectious diseases continue.
Several large-scale studies
In the past few weeks, several vaccine candidates have entered large-scale clinical trials. Tens of thousands take part in voluntary trials of vaccine candidates from Moderna, Pfizer and AstraZeneca. Johnson & Johnson announced that it will enroll approximately 60,000 subjects in its Phase III vaccine study.
The announcement by US President Donald Trump raised concerns about a possible politicization of the regulatory approval process: He announced an emergency approval for a plasma-based treatment method before its benefits were proven in random-controlled, placebo-controlled clinical studies.
Trump tweeted on Saturday that „Deep State“ elements at the US FDA were delaying drug and vaccine advances until after the November 3rd election to jeopardize his re-election offer.
